Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Johnson and Johnson
Moodys
Dow
AstraZeneca

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,056,941

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 6,056,941 protect, and when does it expire?

Patent 6,056,941 protects CARDIOTEC and is included in one NDA.

This patent has ten patent family members in seven countries.

Summary for Patent: 6,056,941
Title: Kit for the preparation of technetium TC 99m teboroxime myocardial perfusion agent
Abstract:A kit containing a solution of boronic acid adducts of technetium-99 m dioxime complexes; and hydroxypropyl gamma cyclodextrin to maintain the solution free of particulate matter originating from the formulation.
Inventor(s): Schramm; Ernest (North Brunswick, NJ), Newborn; Margaret (Hamilton, NJ), Zodda; Julius P. (Mercerville, NJ), Katona; Thomas (Mercerville, NJ), Monteferrante; Jo Anna (Flemington, NJ)
Assignee: Bracco Research USA (Princeton, NJ)
Application Number:09/363,132
Patent Claim Types:
see list of patent claims
Device; Compound;

Drugs Protected by US Patent 6,056,941

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bracco CARDIOTEC technetium tc-99m teboroxime kit INJECTABLE;INJECTION 019928-001 Dec 19, 1990 DISCN No No   See Pricing   See Pricing Y   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,056,941

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 5838400   See Pricing
Australia 763988   See Pricing
Canada 2378096   See Pricing
European Patent Office 1221978   See Pricing
Japan 2003505433   See Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Moodys
Harvard Business School
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.